Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease - Wikidata - wikimedia - TriplyDB

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

http://www.wikidata.org/entity/Q28202050

about

sameAs

Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms Huntingtin is critical both pre- and postsynaptically for long-term learning-related synaptic plasticity in Aplysia The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease Novel nuclear shuttle proteins, HDBP1 and HDBP2, bind to neuronal cell-specific cis-regulatory element in the promoter for the human Huntington's disease gene Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons pARIS-htt: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.Huntingtin in health and disease Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders Multiple Aspects of Gene Dysregulation in Huntington's Disease Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder Human immunodeficiency virus type 1 alters brain-derived neurotrophic factor processing in neurons miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer Brain-derived neurotrophic factor Glutamate and neurotrophic factors in neuronal plasticity and disease Stimulation of NeuroD activity by huntingtin and huntingtin-associated proteins HAP1 and MLK2 Asialoerythropoietin is not effective in the R6/2 line of Huntington's disease mice Association of Huntington's disease and schizophrenia-like psychosis in a Huntington's disease pedigree.The P42 peptide and Peptide-based therapies for Huntington's disease Epigenetics and Triplet-Repeat Neurological Diseases Neurotrophic Factors and Their Potential Applications in Tissue Regeneration.Developing stem cell therapies for juvenile and adult-onset Huntington's disease Defining the role of the Bcl-2 family proteins in Huntington's disease Huntington's disease: the past, present, and future search for disease modifiers.Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System Modeling Huntington's disease with induced pluripotent stem cells Mouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease Fingolimod for the treatment of neurological diseases-state of play and future perspectives Transcriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasis A huntingtin-mediated fast stress response halting endosomal trafficking is defective in Huntington's disease.Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.Amitriptyline improves motor function via enhanced neurotrophin signaling and mitochondrial functions in the murine N171-82Q Huntington disease model.Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease A new drug design targeting the adenosinergic system for Huntington's disease Maintenance of basal levels of autophagy in Huntington's disease mouse models displaying metabolic dysfunction Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disorders Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death

P2860

Q21131050-0D67A2FF-4E99-4208-BDED-72300AC8E087 Q21131986-4D922E58-BFBA-479C-B8FC-27CCD8D6FDAE Q22306292-571ADA11-BD12-4FE7-917F-047F51BE2019 Q24300004-9920AA39-5BE6-4CBD-969A-208E044E3883 Q24311721-19943DAE-0FD6-4718-AF0E-9FCB5D40D52D Q24316303-CC94FC60-578C-453C-8C83-260DA418EE69 Q24337727-82CF13B1-6CF7-471F-98A3-59B0DB7189BC Q24535603-FD8F4F95-E1AE-43C6-9540-07A3588BF7A2 Q24548047-CE8405EB-39DB-4FFA-BC6D-DD84EE04F89F Q24554374-91587DD2-7D21-4E86-948D-4E0BCA6DE924 Q24562763-B083AB1B-78E9-4614-B8C0-8513AFAEDC08 Q24605880-5B91459F-DAB5-4FFF-AA3E-EC8D3309D628 Q24626017-6BD3D58F-47D7-43B8-9474-42770152CE4A Q24628614-5D87BF23-29BB-40CA-AF65-18716C8D234C Q24630894-583D2B99-C745-4F04-B755-3B3482415758 Q24647026-EE67D1EB-ED0A-4577-A9BE-1D6FC4860DD2 Q24653626-6F6B3BB0-5789-4F19-915E-9C9AED9BAD86 Q24681194-9A1F09C3-E9A8-4E46-9B52-1244BBC78078 Q24795623-6279F146-4ED2-4DB6-BC73-4C7CEFD0887A Q25255735-ADB9F416-A518-432A-BF3A-287162BD93F9 Q26764930-B58887FE-2BC1-4E39-8D67-EC5FD6CD8ECA Q26770705-6A285425-D294-4066-97C7-F75749949D60 Q26776474-556E3D92-A30F-4D78-9609-CD99001F93AD Q26799722-2E8DDFBF-7EF8-4F11-A611-E9BA17AD11C9 Q26822846-CA9F56A7-8201-4A81-91A2-6FD61A82482D Q26830039-00A88178-0295-4038-BD43-46A2FD3A046F Q26999386-FC1DF1E1-8805-4E57-A06A-FA32AF74D122 Q27004209-2DEEF762-E593-4128-9025-E811AD9C5289 Q27005950-6616E276-33DE-4033-88B2-500A7914EB94 Q27022757-6B14A01F-8581-49BE-8565-42580D41E883 Q27026175-59040534-69BF-48B9-9970-EE93762B9EF3 Q27026549-93A23AA0-07DF-4BA3-B83D-688382CDBD67 Q27301289-B7425E1C-17B4-4CF3-84CB-83B0B61F0290 Q27306293-EAB2359D-A97C-44A3-BE95-582384E68FDA Q27314860-EE954355-42F1-4C16-B158-F8B6383802AA Q27334872-D7621BD4-8FCD-43A3-810B-BD06FF83CA89 Q27335053-AFBE0CD3-FC81-476E-86A5-DB2D3F4EE4FE Q27341821-00E8CE43-9394-4FF7-A972-F6F20BF02C5F Q28067037-A2AD466E-0FD1-47FC-828B-08426452C3DB Q28069852-3E5395A5-3512-46AE-9FDE-FDB2B5A9E7DC

P2860

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

http://www.wikidata.org/entity/Q28202050

description

2001 nî lūn-bûn

@nan

2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

@ast

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

@en

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

@nl

type

label

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

@ast

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

@en

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

@nl

prefLabel

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

@ast

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

@en

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

@nl

P1433

Q28202050-5F260B46-C6A6-4FE8-8E46-F51B31CB4590

P1476

Q28202050-11EB81EC-E314-4472-83B2-28A61DD639CD

P2093

Q28202050-03DA82FA-0651-48ED-862E-8D8C5DA515ED

Q28202050-07FEBE0A-AF12-400F-BF87-A4356DC71DB7

Q28202050-5D250394-47C1-40E2-B690-5EFCA565025B

Q28202050-881601D6-9510-4840-B5F5-69936CFAEC28

Q28202050-C8B4AFAA-827F-4CA6-89B8-E917D1E07F59

Q28202050-CC80F299-710B-4D9D-AE78-DF06B36755B7

Q28202050-DBBB775A-864D-407B-B67C-83046A54D868

Q28202050-F6B41112-7FC2-4C96-90DB-C99E3A404B72

P304

Q28202050-0D317501-0579-41D4-8A7B-5A39E76AC3CD

P31

Q28202050-451251A2-8240-428B-B3AE-D03753E658BA

P3181

Q28202050-34ACD186-53F3-451E-A869-65AE403237DF

P356

Q28202050-FB559EC1-7987-426D-8156-30F3C7976BC1

P407

Q28202050-DC516A3C-492B-4A85-95A4-8F7EE74B3DB5

P433

Q28202050-A707407D-9ECB-4194-9A6D-BA0AC25F8080

P478

Q28202050-A538122D-950F-4603-9FE1-1244CB9FFBB6

P50

Q28202050-0665ADE4-8F65-44A5-95C1-FD714F7A1102

Q28202050-0779E396-C460-4F1D-AB25-A43E5054ABF5

Q28202050-084A8D5B-0534-4657-833A-96695253AE48

Q28202050-0F88C9F0-415E-472C-AE01-511AF3000922

Q28202050-43B725EC-AEE2-494B-9B7F-0B3963CA8AB5

P577

Q28202050-A153670C-3DBF-44B1-97F2-9EA758525EEB

P698

Q28202050-081DBB2A-DBC0-4C8C-B875-ED8182B7C836

P921

Q28202050-9A4D4BE4-9DA3-44B0-B849-2677BAA2B540

P3181

P356

SCIENCE.1059581

P1433

P1476

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

@en

P2093

A Ciammola

http://www.w3.org/2001/XMLSchema#string

B R Leavitt

http://www.w3.org/2001/XMLSchema#string

D Goffredo

http://www.w3.org/2001/XMLSchema#string

D Rigamonti

http://www.w3.org/2001/XMLSchema#string

M E MacDonald

http://www.w3.org/2001/XMLSchema#string

R M Friedlander

http://www.w3.org/2001/XMLSchema#string

S Sipione

http://www.w3.org/2001/XMLSchema#string

T Timmusk

http://www.w3.org/2001/XMLSchema#string

P304

493-498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3397970

http://www.w3.org/2001/XMLSchema#string

P356

10.1126/SCIENCE.1059581

http://www.w3.org/2001/XMLSchema#string

P407

P433

5529

http://www.w3.org/2001/XMLSchema#string

P478

293

http://www.w3.org/2001/XMLSchema#string

P50

Vincenzo Silani

Michael R. Hayden

P577

2001-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11408619

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease